Researcher.Life Logo

Journal of Cardiovascular Pharmacology and Therapeutics : Impact Factor & More

eISSN: 1940-4034pISSN: 1074-2484
JournalOpen Access

Aims and Scope of Journal of Cardiovascular Pharmacology and Therapeutics

Journal of Cardiovascular Pharmacology and Therapeutics is a quarterly peer-reviewed medical journal that covers cardiology. The editor-in-chief is Karin Przyklenk (Wayne State University) and the founding editor is Bramah N. Singh (University of California, Los Angeles). It was established in 1996 and is published by Sage Publications. Less

Key Metrics

CiteScore
4.2
H-Index
55
Impact Factor
< 5
SJR
Q2Pharmacology
SNIP
0.73
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Cardiovascular Pharmacology and Therapeutics

Journal of Cardiovascular Pharmacology and Therapeutics Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher SAGE PUBLICATIONS INC
Language English
Frequency Bi-monthly
Article Processing ChargesUSD 2000
Publication Time12
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1995
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 12
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC
OA statementVisit website
View less

Planning to publish in Journal of Cardiovascular Pharmacology and Therapeutics ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Cardiovascular Pharmacology and Therapeutics

Intravenous Canrenone in Paroxysmal Atrial Fibrillation: A Reappraisal of Clinical Utility.
  • 1 May 2026
  • Journal of cardiovascular pharmacology and therapeutics
Multiomics Mendelian Randomization of GWAS, eQTL, and pQTL Combined With Drug Analysis to Predict Drug Targets in Myocardial Infarction.
  • 1 Apr 2026
  • Journal of cardiovascular pharmacology and therapeutics
Factors Associated With the Selection of Anti-Hypertensive Medications: A Retrospective Cross-Sectional Analysis.
  • 1 Mar 2026
  • Journal of cardiovascular pharmacology and therapeutics
Underuse of Guideline-Directed Medical Therapy Across Heart Failure Phenotypes in Older Outpatients: A Multicenter Cross-Sectional Study in Vietnam.
  • 1 Mar 2026
  • Journal of cardiovascular pharmacology and therapeutics
Thanks to Reviewers
  • 1 Mar 2026
  • Journal of Cardiovascular Pharmacology and Therapeutics
Comparative Effect of Ticagrelor and Clopidogrel on Left Ventricular Remodeling in Acute Coronary Syndrome Patients: A Retrospective Cohort Study.
  • 1 Mar 2026
  • Journal of cardiovascular pharmacology and therapeutics
Intravenous Canrenone in Paroxysmal Atrial Fibrillation: A Reappraisal of Clinical Utility.
  • 1 May 2026
  • Journal of cardiovascular pharmacology and therapeutics
Multiomics Mendelian Randomization of GWAS, eQTL, and pQTL Combined With Drug Analysis to Predict Drug Targets in Myocardial Infarction.
  • 1 Apr 2026
  • Journal of cardiovascular pharmacology and therapeutics
Factors Associated With the Selection of Anti-Hypertensive Medications: A Retrospective Cross-Sectional Analysis.
  • 1 Mar 2026
  • Journal of cardiovascular pharmacology and therapeutics
Underuse of Guideline-Directed Medical Therapy Across Heart Failure Phenotypes in Older Outpatients: A Multicenter Cross-Sectional Study in Vietnam.
  • 1 Mar 2026
  • Journal of cardiovascular pharmacology and therapeutics
Thanks to Reviewers
  • 1 Mar 2026
  • Journal of Cardiovascular Pharmacology and Therapeutics
Comparative Effect of Ticagrelor and Clopidogrel on Left Ventricular Remodeling in Acute Coronary Syndrome Patients: A Retrospective Cohort Study.
  • 1 Mar 2026
  • Journal of cardiovascular pharmacology and therapeutics

FAQs on Journal of Cardiovascular Pharmacology and Therapeutics